Boyack v. GlaxoSmithKline, LLC
| Ember Lambert Boyack |
| GlaxoSmithKline, LLC |
| 1:2018cv11874 |
| August 31, 2018 |
| US District Court for the District of Massachusetts |
| F Dennis Saylor |
| Personal Inj. Prod. Liability |
| 28 U.S.C. ยง 1332 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 10, 2018. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 Electronic Clerk's Notes for proceedings held before Judge F. Dennis Saylor, IV: Hearing held on 10/10/2018.(1) The Court heard updates on the current total of federal and state filings.(2) The Court heard updates on pending state court cases.(3) The Court heard updates on fact and expert discovery.(4) The Court heard updates on Phase 5 in light of recently issued MDL Order No. 27 Supplementing MDL Order No. 25 Related to Phase 5 Discovery and Lexecon Waivers.(5) The Court heard the parties' "science day" presentations. (Court Reporter: Valerie OHara for 10:00-10:30 AM status only -- at vaohara@gmail.com.)(Attorneys present: Various) Associated Cases: 1:15-md-02657-FDS et al.(Pezzarossi, Lisa) |
| Filing 8 NOTICE: The Court will conduct a brief status conference on 10/10/2018 beginning at 10:00 AM and concluding at 10:30 AM. Parties who intend to participate in the status conference via telephone, must use the following DIAL-IN INSTRUCTIONS: (1) the participant dial-in number is 877-876-9177 and (2) Conference ID: ZOFRAN. The operator will ask for the Conference ID when dialing in. The phone line is open at 9:45 AM. Associated Cases: 1:15-md-02657-FDS et al.(Pezzarossi, Lisa) |
| Filing 6 NOTICE of Appearance by Jennifer M. Stevenson on behalf of GlaxoSmithKline, LLC (Stevenson, Jennifer) |
| Filing 7 Electronic Clerk's Notes for proceedings held before Judge F. Dennis Saylor, IV: Status Conference held on 9/13/2018.(1) The Court heard updates on the current total of federal and state filings. (2) The Court heard updates on pending state court cases. (3) The Court heard updates on fact and expert discovery. (4) The Court heard updates on Phase 5, including the status of Lexecon waivers. Colloquies were held on the possible extension of Phase 5 deadlines and on motions to dismiss certain defense selections. The Court directed the parties to submit a proposed MDL order related to Phase 5 discovery and Lexecon waivers. (5) The Court heard updates on plaintiffs' motion to amend the master complaints and took the matter under advisement. (6) A colloquy was held on logistics for the upcoming "science day" scheduled for October 10, 2018. (7) The Court heard argument on GSK's motion for summary judgment on preemption grounds and took the matter under advisement. (Court Reporter: Valerie OHara at vaohara@gmail.com.)(Attorneys present: Various) Associated Cases: 1:15-md-02657-FDS et al.(Pezzarossi, Lisa) |
| Filing 5 NOTICE RE: 9/13/2018 9:00 AM STATUS CONFERENCE: Parties participating in the 9/13/2018 status conference scheduled to begin at 9:00 AM must use the following DIAL-IN INSTRUCTIONS: (1) the participant dial-in number is 877-876-9173 and (2) Conference ID: HEARING. The operator will ask for the Conference ID when dialing in. The phone line is open at 8:45 AM. Associated Cases: 1:15-md-02657-FDS et al.(Pezzarossi, Lisa) |
| Filing 4 Summons Issued as to GlaxoSmithKline, LLC. Counsel receiving this notice electronically should download this summons, complete one for each defendant and serve it in accordance with Fed.R.Civ.P. 4 and LR 4.1. Summons will be mailed to plaintiff(s) not receiving notice electronically for completion of service. (McKillop, Matthew) |
| Filing 3 NOTICE OF MDL CASE OPENED, Direct file in the District of Massachusetts; 1:18-cv-11874-FDS Boyack v. GlaxoSmithKline, LLC. In Re: Zofran (Ondansetron) Products Liability Litigation, MDL 2657. (Danieli, Chris) |
| Filing 2 ELECTRONIC NOTICE of Case Assignment. Judge F. Dennis Saylor, IV assigned to case. (Danieli, Chris) |
| Filing 1 COMPLAINT against GlaxoSmithKline, LLC Filing fee: $ 400, receipt number 0101-7299907 (Fee Status: Filing Fee paid), filed by Ember Lambert Boyack. (Attachments: #1 Civil Cover Sheet, #2 Category Form)(Ayala, Thomas) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Massachusetts District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
| Search for this case: Boyack v. GlaxoSmithKline, LLC | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Plaintiff: Ember Lambert Boyack | |
| Represented By: | Thomas V. Ayala |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Defendant: GlaxoSmithKline, LLC | |
| Represented By: | Jennifer M. Stevenson |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
